Announcements

Showing items 11 - 20 of 4863 stories.

Hodder receives continued funding for clinical research center

Dr. Sally Hodder, WVCTSI director, associate vice president for clinical and translational science and Preeminent Scholar Chair at West Virginia University Health Sciences, has received notification of continued funding for the research project “The IDeA State Consortium for a Clinical Research Resource Center Increasing Clinical Trials in IDeA States through Communication of Opportunities Effective Marketing and Workforce Development.”

Damron receives continued funding for pertussis research

Heath Damron, professor and director of the Vaccine Development Center in the West Virginia University School of Medicine Department of Microbiology, Immunology and Virology and director of the MD-PhD Program in the Health Science Center Department of Research and Graduate Education, has received notification of R56 award funding for the research project “Development of therapies against pertussis.”

Lockman receives continued funding for Tumor Microenvironment research

Paul Lockman, Ph.D., BSN, assistant vice president of Experimental Therapeutics in the West Virginia University School of Medicine Department of Pharmacology and Benedum Fellow and the Mylan Endowed Chair professor in the School of Pharmacy, has received notification of continued funding for the research project “Tumor Microenvironment-TME CoBRE.”

WVU Medicine physician enrolls their first patient in global periprosthetic joint infection clinical trial

WVU Medicine physicians are participating in their second Peptilogics study to treat peri-prosthetic joint infections (PJI) of the knee, which is infection after joint replacement surgery. In 2022, WVU was the first site to dose a patient with a new antimicrobial medication in the Phase 1b clinical trial for the treatment of PJI.  WVU, led by Principal Investigator Dr. Matthew Dietz, is now collaborating on the follow up study, a global Phase 2/3 RETAIN trial, onto which the team has already enrolled its first patient.